drugset / Trial / NCT00025129

VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas

NCT00025129

Phase 1 Completed Vion Pharmaceuticals
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of VNP40101M in treating patients who have advanced solid tumors or lymphomas.

Timeline

Start
2001-03
Primary completion
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject laromustine Other / unclassified Intravenous